P1165: PRELIMINARY FINDINGS OF A PHASE Ⅱ STUDY OF CHEMO-FREE COMBINATION OF POMALIDOMIDE, ORELABRUTINIB, RITUXIMAB WITH SEQUENTIAL HIGH-DOSE METHOREXATE IN NEWLY DIAGNOSED PRIMARY CNS LYMPHOMA

• Yan Zhang,
• Chao Chen,
• Danqing Zhao,
• Zhe Zhuang,
• Chong Wei,
• Wei Wang,
• Wei Zhang,
• Dao-Bin Zhou

Affiliations

Yan Zhang

1 Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Department of Hematology, Beijing, China

Chao Chen

1 Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Department of Hematology, Beijing, China

Danqing Zhao

1 Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Department of Hematology, Beijing, China

Zhe Zhuang

1 Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Department of Hematology, Beijing, China

Chong Wei

1 Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Department of Hematology, Beijing, China

Wei Wang

1 Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Department of Hematology, Beijing, China

Wei Zhang

1 Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Department of Hematology, Beijing, China

Dao-Bin Zhou

1 Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Department of Hematology, Beijing, China